Who asks about DSIP and the sleep questions behind it

A near-50-year-old sleep peptide with a great name and surprisingly thin human evidence.

TL;DR

DSIP (delta sleep-inducing peptide) is a small molecule named for deep-sleep effects seen in 1970s animal studies. Human evidence is thin and mixed. It is not FDA-approved and sits in the FDA’s Category 2 for compounding. People ask about it mainly because sleep problems are so common.

Who asks about DSIP

People who ask about DSIP are usually tired, curious, and out of easy answers. They have often tried the basics — better sleep habits, less caffeine, melatonin — and are scanning for something new. The search is driven by a real problem: restless nights that ordinary fixes have not solved.

What it is

DSIP is short for delta sleep-inducing peptide (in plain English: a tiny protein fragment first linked to deep sleep). It is a chain of nine amino acids, the building blocks of proteins. Researchers isolated it from rabbit brain in the late 1970s. The name captures a hope more than a proven job, because its true function in humans remains unclear.

How it works

Honest answer: no one fully knows. Think of DSIP as a note found in the body’s mailroom with no confirmed address. Early studies suggested it might nudge the brain toward slow-wave sleep, the deepest, most restorative stage. But it does not behave like a simple sleeping pill, and its signaling pathways in people are still being mapped.

What the research says

The literature is old, small, and inconsistent. DSIP was first isolated and named for inducing delta (deep) sleep in rabbits (Schoenenberger and Monnier, PNAS, 1977). Later human studies were limited and produced mixed results, and reviews have noted its effects are hard to reproduce (Kovalzon, 1983). So the science is interesting history more than a settled sleep therapy.

What to know before considering it

A memorable name is not evidence of benefit or safety. DSIP is not approved, human dosing is not well established, and reliable long-term safety data is missing. Anyone exploring peptides for sleep should work with a licensed clinician and avoid unregulated online sellers.

The Halftime POV

We include DSIP because members ask, not because it is a proven answer for sleep. For most people, the highest-yield sleep work is unglamorous: consistent timing, light exposure, and ruling out issues like apnea with a clinician. We would rather point you there first.

Related reading:

• Sleep quality and aging research
• How sleep deprivation disrupts hormones
• Who asks about longevity
• Why some peptides are still Category 2

FAQ

What is DSIP peptide? DSIP stands for delta sleep-inducing peptide, a nine-amino-acid molecule first isolated from rabbit brain in 1977. It was named for a link to deep sleep in animals. Its exact role in humans is still unclear.

Does DSIP help with sleep? The human evidence is thin and mixed. Early animal work inspired the name, but controlled human trials have been small and inconsistent. There is no reliable proof it improves sleep in people.

Is DSIP FDA-approved? No. DSIP is not FDA-approved and sits in the FDA’s Category 2 for pharmacy compounding, so it is not currently cleared for routine 503A compounding.

Disclaimer

As of July 2026, several peptides discussed in this article — including DSIP — are classified by the FDA as Category 2, which means they are not currently available from 503A compounding pharmacies. A February 2026 HHS announcement proposed returning these peptides to Category 1 pending formal FDA Federal Register notice. This article is educational and is not medical advice. Halftime Health only prescribes through licensed clinicians in states where our partner physicians are credentialed.

Get updates

Want evidence-first takes on sleep and longevity? Join the waitlist and we’ll email you when we’re live.

Sources

• Schoenenberger GA, Monnier M. “Characterization of a delta-electroencephalogram (sleep)-inducing peptide.” Proceedings of the National Academy of Sciences, 1977. PMC431129.
• Kovalzon VM, Strekalova TV. “Delta sleep-inducing peptide (DSIP): a still unresolved riddle.” Reviewed human and animal findings. PubMed 6889859, 1983.
• U.S. Food and Drug Administration. “Bulk Drug Substances Nominated for Use in Compounding Under Section 503A.” FDA, 2023.